| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $14.8M | — | +19.6% |
| Cost of Revenue | $1.9M | — | -7.3% |
| Gross Profit | $12.9M | — | +24.9% |
| R&D Expense | $3.1M | — | +22.5% |
| SG&A Expense | $22.0M | — | +3.4% |
| Operating Income | -$12.2M | — | +9.5% |
| Pre-tax Income | -$13.1M | — | +4.7% |
| Income Tax | $1K | — | +120.0% |
| Net Income | -$13.1M | — | +4.7% |
| EPS (Basic) | -$0.50 | — | +5.7% |
| EPS (Diluted) | -$0.50 | — | +5.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $72.3M | -4.5% | -29.6% |
| Accounts Receivable | $9.1M | -14.6% | +1.0% |
| Inventory | $12.4M | +1.6% | +6.3% |
| Current Assets | $96.8M | -4.8% | -23.3% |
| Total Assets | $99.7M | -4.8% | -23.0% |
| Current Liabilities | $9.5M | -28.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$12.2M | — | +4.7% |
| Capital Expenditures | $122K | — | +7.0% |
| Investing Cash Flow | -$122K | — | -7.0% |
| Financing Cash Flow | $8.9M | — | -7.6% |
| Free Cash Flow | -$12.3M | — | +4.6% |
| +11.5% |
| Long-term Debt | $58.5M | +18.1% | +18.6% |
| Total Liabilities | $70.6M | +7.9% | +17.3% |
| Stockholders' Equity | $29.1M | -26.0% | -58.0% |